Tag Archives: BPEA EQT

EQT Announces Successful Completion of USD 924 Million Block Trade for Coforge

(IN BRIEF) BPEA Private Equity Fund VII (“BPEA EQT”) has successfully sold its remaining 26.6 percent stake in Coforge, an Indian technology services provider listed on the National Stock Exchange. The USD 924 million block trade marked the conclusion of … Read the full press release

BPEA EQT to acquire IMG Academy from Endeavor Group Holdings for $1.25 billion

(IN BRIEF) BPEA Private Equity Fund VIII, an affiliated investment fund of BPEA EQT, is set to acquire IMG Academy from Endeavor Group Holdings for USD 1.25 billion. IMG Academy, headquartered in Florida, provides a sports-focused boarding school, sports camps, … Read the full press release

El proveedor chino de soluciones de pago VBill recompra acciones del fondo EQT Mid Market Asia III

(NOTICIA EN BREVE) El fondo Mid Market Asia III de la firma de capital privado EQT ha vendido su participación minoritaria en el proveedor chino de soluciones de pago VBill a la compañía a través de una opción de venta. … Read the full press release

Chinese payment solutions provider VBill buys back shares from EQT Mid Market Asia III fund

(IN BRIEF) Private equity firm EQT’s Mid Market Asia III fund has sold its minority stake in Chinese payment solutions provider VBill back to the company through a put option. The investment was made in 2019 and the exit was … Read the full press release

EQT BPEA V Fund to exit from Bushu Pharmaceuticals, one of the leading CDMOs in Japan

(PRESS RELEASE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, a purpose-driven global investment organization, has announced that its BPEA V Fund will divest Bushu Pharmaceuticals, a leading CMO in Japan that produces high-quality pharmaceutical and medical devices, by selling it to … Read the full press release

EQT BPEA V Fund se retire de Bushu Pharmaceuticals, l’un des principaux CDMO au Japon

(COMMUNIQUÉ DE PRESSE) STOCKHOLM, 20-Dec-2022 — /EuropaWire/ — EQT, une organisation d’investissement mondiale axée sur les objectifs, a annoncé que son fonds BPEA V cèdera Bushu Pharmaceuticals, un chef de file du marketing au Japon qui produit des des dispositifs … Read the full press release